Rocaltrol is indicated in the management of secondary hyperparathyroidism and resultant metabolic bone disease in patients with moderate to severe chronic renal failure (Ccr 15 to 55 mL/min) not yet on dialysis. In children, the creatinine clearance value must be corrected for a surface area of 1.73 square meters. A serum iPTH level of ≥ 100 pg/mL is strongly suggestive of secondary hyperparathyroidism.
Rocaltrol is indicated in the management of hypocalcemia and the resultant metabolic bone disease in patients undergoing chronic renal dialysis. In these patients, Rocaltrol administration enhances calcium absorption, reduces serum alkaline phosphatase levels, and may reduce elevated parathyroid hormone levels and the histological manifestations of osteitis fibrosa cystica and defective mineralization.
Rocaltrol is also indicated in the management of hypocalcemia and its clinical manifestations in patients with postsurgical hypoparathyroidism, idiopathic hypoparathyroidism, and pseudohypoparathyroidism.
Calcitriol is a form of vitamin D that is used to treat and prevent low levels of calcium in the blood of patients whose kidneys or parathyroid glands (glands in the neck that release natural substances to control the amount of calcium in the blood) are not working normally. Low blood levels of calcium may cause bone disease. Calcitriol is in a class of medications called vitamins. It works by helping the body to use more of the calcium found in foods or supplements.
However for more info do seek medical advice, please.
Take care, best wishes!
- Rocaltrol Information for Consumers
- Rocaltrol Information for Healthcare Professionals (includes dosage details)
- Side Effects of Rocaltrol (detailed)
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 3 Dec 2012 • 2 answers
Posted 22 Oct 2013 • 2 answers
Posted 26 Dec 2013 • 3 answers
Posted 1 Aug 2014 • 1 answer
Posted 4 Oct 2015 • 3 answers